当前位置: X-MOL 学术Chem. Commun. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A mitochondria-targeting hetero-binuclear Ir(iii)–Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells†
Chemical Communications ( IF 4.9 ) Pub Date : 2018-05-25 00:00:00 , DOI: 10.1039/c8cc02795a
Cheng Ouyang 1, 2, 3, 4, 5 , Lei Chen 6, 7, 8, 9, 10 , Thomas W. Rees 1, 2, 3, 4, 5 , Yu Chen 1, 2, 3, 4, 5 , Jiankang Liu 6, 7, 8, 9, 10 , Liangnian Ji 1, 2, 3, 4, 5 , Jiangang Long 6, 7, 8, 9, 10 , Hui Chao 1, 2, 3, 4, 5
Affiliation  

A hetero-binuclear Ir(III)–Pt(II) complex was developed as an antitumor agent. In vitro cytotoxicity results indicated that this complex was effective against cisplatin-resistant tumor cells. Mechanism experiments showed that it can overcome cisplatin resistance by increasing cellular uptake, targeting mitochondria, and inducing cell necrosis.

中文翻译:

靶向线粒体的异双核Ir(iii)–Pt(ii)复合物在顺铂耐药肿瘤细胞中诱导坏死

杂双核的Ir(III)–Pt(II)复合物被开发为抗肿瘤剂。体外细胞毒性结果表明,该复合物可有效抵抗顺铂耐药的肿瘤细胞。机理实验表明,它可以通过增加细胞摄取,靶向线粒体和诱导细胞坏死来克服顺铂耐药性。
更新日期:2018-05-25
down
wechat
bug